Biotechnology · Healthcare
Chairman, Board Member
2025-11-10–present
Chairman
Damora Therapeutics, Inc. (DMRA)Board Member
Damora Therapeutics, Inc. (DMRA)Equibles does not estimate personal net worth.
Get an email with a short summary when Damora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DMRA alertsPeter Harwin is recorded as Chairman at Damora Therapeutics, Inc. (DMRA) since March 23, 2026 and Board Member at Damora Therapeutics, Inc. (DMRA) since November 10, 2025. Damora Therapeutics, Inc. reported in an 8-K filed March 23, 2026 that Peter Harwin was appointed Chairman of the Board of Directors. Damora Therapeutics, Inc. reported in an 8-K filed March 23, 2026 that Peter Harwin was appointed chair of the Board, effective March 23, 2026. Damora Therapeutics, Inc. reported in an 8-K filed November 10, 2025 that Peter Harwin was appointed Board, effective November 10, 2025. Damora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Damora Therapeutics, Inc. includes Jennifer Jarrett (CEO and Board Member), Sherwin Sattarzadeh (CEO and COO), Lori Firmani (CFO) and 7 others.
“Peter Harwin, Founding Partner at Fairmount Funds Management, LLC, and a current member of Damora's Board of Directors, has been named Chairman.”
“Also effective as of March 23, 2026, the Board decreased its size from seven to six members and appointed Peter Harwin as the chair of the Board.”
2026-03-23–present
2025-11-10–present
Biotechnology · Healthcare
Chairman, Board Member
2025-11-10–present